Latest update:
  • 1

    China's Aesthetic Medicine Body Contouring Industry

    In 2020, the market size of China's aesthetic medicine and body contouring industry was 15.05 billion RMB and will reach 41.78 billion RMB in 2025, with a CAGR of 22.7%. Its main growth momentum arises from people’s changing concept of beauty, as well as increasing acceptance and penetration rate of medical beauty. This report will mainly explore the current market for medical aesthetic body contouring, the key driver for its growth and beauty-seekers' attitude toward this new service.

  • 2

    Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital

    “I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”

  • 3

    15 Chinese Companies to Watch in April 2022 – Healthcare

    Editor's note: We at EqualOcean tracked the major funding rounds or industry events that took place in China’s healthcare space in April 2022. And the following is a list of deals that we have selected for you, based on a number of criteria including the funding amount, the financial backers, and the segments in which the startups operate.

  • 4

    WIA2020 | 30 Tech Entrepreneurs in China

    This research includes 150 entrepreneurs who operate the most promising technology-based businesses in China. The candidates have been selected based on five distinct categories, including professional background and business achievements. The report is a helpful resource for institutional investors seeking groundbreaking businesses in China, as well as for international corporations that are looking for partnerships in the local market.

Trending

Price

48.00 HK -7(-12.73%)

Dashenlin

603233:SSE

Price

31.48 RMB 2.86(+9.99%)

Microport

00853:HKEX

Price

13.94 HK -1.44(-9.36%)

Tigermed

03347:HKEX

Price

71.20 HK -6.92(-8.86%)

Autek

300595:SZSE

Price

37.91 RMB 2.74(+7.79%)

Innovent

01801:HKEX

Price

20.80 HK -1.75(-7.76%)

BeiGene

06160:HKEX

Price

78.60 HK -5.7(-6.76%)

Hualan Bio

002007:SZSE

Price

20.44 RMB 1.21(+6.29%)

WEGO

01066:HKEX

Price

7.99 HK -0.48(-5.67%)

WuXi Biologics

02269:HKEX

Price

53.10 HK -3.15(-5.6%)

Hygeia

06078:HKEX

Price

36.65 HK -1.75(-4.56%)

SPH

02607:HKEX

Price

12.12 HK -0.54(-4.27%)

Autobio

603658:SSE

Price

44.30 RMB 1.67(+3.92%)

Hualan Vaccine

301207:SZSE

Price

48.32 RMB -1.78(-3.55%)

Meinian Onehealth

002044:SZSE

Price

5.00 RMB 0.16(+3.31%)

Ali Health

00241:HKEX

Price

3.87 HK -0.13(-3.25%)

Price

19.04 HK -0.54(-2.76%)

Tong Ren Tang

03613:HKEX

Price

10.20 HK -0.28(-2.67%)

Snibe Diagnostic

300832:SZSE

Price

40.39 RMB 0.99(+2.51%)

Team
Ang Gao

Ang Gao

Managing Director

Contact

Yongsheng Liang

Yongsheng Liang

Director (Healthcare BU)

Contact

Cong Liu

Cong Liu

Chief Editor (Healthcare BU)

Contact

Qiong Tao

Qiong Tao

Associate Director of BD

Contact